A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors

PURPOSE: To define maximum tolerated dose (MTD), clinical toxicities, and pharmacokinetics of 17-allylamino-17-demethoxygeldanamycin (17-AAG) when administered in combination with docetaxel once every 21 days in patients with advanced solid tumor malignancies. EXPERIMENTAL DESIGN: Docetaxel was admi...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Iyer, Gopa, Morris, Michael J., Rathkopf, Dana, Slovin, Susan F., Steers, Macaulay, Larson, Steven M., Schwartz, Lawrence H., Curley, Tracy, DeLaCruz, Anthony, Ye, Qing, Heller, Glenn, Egorin, Merrill J., Ivy, S. Percy, Rosen, Neal, Scher, Howard I., Solit, David B.
格式: Artigo
語言:Inglês
出版: 2011
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3471133/
https://ncbi.nlm.nih.gov/pubmed/22124669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-011-1789-3
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍